Literature DB >> 18239666

Association of common JAK2 variants with body fat, insulin sensitivity and lipid profile.

Dongliang Ge1, Sakina B Gooljar, Theodosios Kyriakou, Laura J Collins, Ramasamyiyer Swaminathan, Harold Snieder, Tim D Spector, Sandra D O'Dell.   

Abstract

The leptin signal is transduced via the JAK2-STAT3 (Janus kinase 2-signal transducer and activator of transcription-3) pathway at the leptin receptor. JAK2 also phosphorylates insulin receptor substrate, integral to insulin and leptin action and is required for optimum adenosine triphosphate-binding cassette transporter A1 (ABCA1)-dependent transport of lipids from cells to apolipoprotein A-1 (apoA-I). We hypothesized that common variation in the JAK2 gene may be associated with body fat, insulin sensitivity, and modulation of the serum lipid profile in the general population. Ten tagging single-nucleotide polymorphisms (SNPs) spanning the gene were genotyped in 2,760 white female twin subjects (mean age 47.3 +/- 12.6 years) from the St Thomas' UK Adult Twin Registry. Minor allele frequencies were between 0.170 and 0.464. The major allele of rs7849191 was associated with higher central fat (P = 0.030), percentage of central fat (P = 0.014) and waist circumference (P = 0.027) the major allele of rs3780378 with higher serum apoA (P = 0.026), total cholesterol (P = 0.014), low-density lipoprotein (LDL) cholesterol (P = 0.012) and lower triglyceride (P = 0.023). However, no associations were significant at a level which took account of multiple testing. Although JAK2 is a critical element in leptin and insulin signaling and has a role in cellular cholesterol transport, we failed to establish associations of common SNPs with relevant phenotypes in this human study.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18239666      PMCID: PMC2289869          DOI: 10.1038/oby.2007.79

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  20 in total

1.  A comparison of bayesian methods for haplotype reconstruction from population genotype data.

Authors:  Matthew Stephens; Peter Donnelly
Journal:  Am J Hum Genet       Date:  2003-10-20       Impact factor: 11.025

2.  Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous.

Authors:  S L Lake; H Lyon; K Tantisira; E K Silverman; S T Weiss; N M Laird; D J Schaid
Journal:  Hum Hered       Date:  2003       Impact factor: 0.444

3.  Detecting disease associations due to linkage disequilibrium using haplotype tags: a class of tests and the determinants of statistical power.

Authors:  Juliet M Chapman; Jason D Cooper; John A Todd; David G Clayton
Journal:  Hum Hered       Date:  2003       Impact factor: 0.444

4.  Testing association between candidate-gene markers and phenotype in related individuals, by use of estimating equations.

Authors:  D A Trégouët; P Ducimetière; L Tiret
Journal:  Am J Hum Genet       Date:  1997-07       Impact factor: 11.025

5.  Protein tyrosine phosphatase-1B gene PTPN1: selection of tagging single nucleotide polymorphisms and association with body fat, insulin sensitivity, and the metabolic syndrome in a normal female population.

Authors:  Nicola J Spencer-Jones; Xiaoling Wang; Harold Snieder; Tim D Spector; Nicholas D Carter; Sandra D O'Dell
Journal:  Diabetes       Date:  2005-11       Impact factor: 9.461

Review 6.  HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol.

Authors:  John F Oram
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-09       Impact factor: 8.311

7.  Janus kinase 2 modulates the apolipoprotein interactions with ABCA1 required for removing cellular cholesterol.

Authors:  Chongren Tang; Ashley M Vaughan; John F Oram
Journal:  J Biol Chem       Date:  2003-12-09       Impact factor: 5.157

8.  Obesity reveals an association between blood pressure and the G-protein beta3-subunit gene: a study of female dizygotic twins.

Authors:  Yanbin Dong; Haidong Zhu; Xiaoling Wang; Chrysoula Dalageorgou; Nick Carter; Tim D Spector; Harold Snieder
Journal:  Pharmacogenetics       Date:  2004-07

9.  Divergent signaling capacities of the long and short isoforms of the leptin receptor.

Authors:  C Bjørbaek; S Uotani; B da Silva; J S Flier
Journal:  J Biol Chem       Date:  1997-12-19       Impact factor: 5.157

Review 10.  Leptin and the regulation of body weight in mammals.

Authors:  J M Friedman; J L Halaas
Journal:  Nature       Date:  1998-10-22       Impact factor: 49.962

View more
  5 in total

1.  Haplotype kernel association test as a powerful method to identify chromosomal regions harboring uncommon causal variants.

Authors:  Wan-Yu Lin; Nengjun Yi; Xiang-Yang Lou; Degui Zhi; Kui Zhang; Guimin Gao; Hemant K Tiwari; Nianjun Liu
Journal:  Genet Epidemiol       Date:  2013-06-05       Impact factor: 2.135

2.  Exercise training decreases plasma leptin levels and the expression of hepatic leptin receptor-a, -b, and, -e in rats.

Authors:  Siham Yasari; Donghao Wang; Denis Prud'homme; Marek Jankowski; Jolanta Gutkowska; Jean-Marc Lavoie
Journal:  Mol Cell Biochem       Date:  2008-12-13       Impact factor: 3.396

3.  Association of common variants in JAK2 gene with reduced risk of metabolic syndrome and related disorders.

Authors:  Alberto Penas-Steinhardt; Mariana L Tellechea; Leonardo Gomez-Rosso; Fernando Brites; Gustavo D Frechtel; Edgardo Poskus
Journal:  BMC Med Genet       Date:  2011-12-20       Impact factor: 2.103

4.  Association between markers of systemic inflammation, oxidative stress, lipid profiles, and insulin resistance in pregnant women.

Authors:  Zatollah Asemi; Shima Jazayeri; Mohammad Najafi; Mansooreh Samimi; Farzad Shidfar; Zohreh Tabassi; Mohamadesmaeil Shahaboddin; Ahmad Esmaillzadeh
Journal:  ARYA Atheroscler       Date:  2013-05

5.  Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms.

Authors:  Manali Sapre; Douglas Tremblay; Eric Wilck; Annie James; Amanda Leiter; Alexander Coltoff; Anita G Koshy; Marina Kremyanskaya; Ronald Hoffman; John O Mascarenhas; Emily J Gallagher
Journal:  Sci Rep       Date:  2019-11-12       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.